TY - JOUR AU - Heintz, A. P. AU - Odicino, F. AU - Maisonneuve, P. AU - Quinn, M. A. AU - Benedet, J. L. AU - Creasman, W. T. PY - 2006 DA - 2006// TI - Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer JO - Int J Gynaecol Obstet VL - 95 UR - https://doi.org/10.1016/S0020-7292(06)60033-7 DO - 10.1016/S0020-7292(06)60033-7 ID - Heintz2006 ER - TY - JOUR AU - Wright, J. D. AU - Chen, L. AU - Tergas, A. I. AU - Patankar, S. AU - Burke, W. M. AU - Hou, J. Y. PY - 2015 DA - 2015// TI - Trends in relative survival for ovarian cancer from 1975 to 2011 JO - Obstet Gynecol VL - 125 UR - https://doi.org/10.1097/AOG.0000000000000854 DO - 10.1097/AOG.0000000000000854 ID - Wright2015 ER - TY - JOUR AU - Chan, J. K. AU - Cheung, M. K. AU - Husain, A. AU - Teng, N. N. AU - West, D. AU - Whittemore, A. S. PY - 2006 DA - 2006// TI - Patterns and progress in ovarian cancer over 14 years JO - Obstet Gynecol VL - 108 UR - https://doi.org/10.1097/01.AOG.0000231680.58221.a7 DO - 10.1097/01.AOG.0000231680.58221.a7 ID - Chan2006 ER - TY - JOUR AU - Corrado, G. AU - Salutari, V. AU - Palluzzi, E. AU - Distefano, M. G. AU - Scambia, G. AU - Ferrandina, G. PY - 2017 DA - 2017// TI - Optimizing treatment in recurrent epithelial ovarian cancer JO - Expert Rev Anticancer Ther VL - 17 UR - https://doi.org/10.1080/14737140.2017.1398088 DO - 10.1080/14737140.2017.1398088 ID - Corrado2017 ER - TY - JOUR AU - Pignata, S. AU - C Cecere, S. AU - Bois, A. AU - Harter, P. AU - Heitz, F. PY - 2017 DA - 2017// TI - Treatment of recurrent ovarian cancer JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx441 DO - 10.1093/annonc/mdx441 ID - Pignata2017 ER - TY - JOUR AU - Tohme, S. AU - Simmons, R. L. AU - Tsung, A. PY - 2017 DA - 2017// TI - Surgery for Cancer: a trigger for metastases JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-1536 DO - 10.1158/0008-5472.CAN-16-1536 ID - Tohme2017 ER - TY - JOUR AU - Fisher, B. AU - Gunduz, N. AU - Saffer, E. A. PY - 1983 DA - 1983// TI - Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases JO - Cancer Res VL - 43 ID - Fisher1983 ER - TY - JOUR AU - Gagliato Dde, M. AU - Gonzalez-Angulo, A. M. AU - Lei, X. AU - Theriault, R. L. AU - Giordano, S. H. AU - Valero, V. PY - 2014 DA - 2014// TI - Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.49.7693 DO - 10.1200/JCO.2013.49.7693 ID - Gagliato Dde2014 ER - TY - JOUR AU - Biagi, J. J. AU - Raphael, M. J. AU - Mackillop, W. J. AU - Kong, W. AU - King, W. D. AU - Booth, C. M. PY - 2011 DA - 2011// TI - Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis JO - Jama. VL - 305 UR - https://doi.org/10.1001/jama.2011.749 DO - 10.1001/jama.2011.749 ID - Biagi2011 ER - TY - JOUR AU - Larsen, E. AU - Blaakaer, J. PY - 2009 DA - 2009// TI - Epithelial ovarian cancer: does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance? JO - Acta Obstet Gynecol Scand VL - 88 UR - https://doi.org/10.1080/00016340902814559 DO - 10.1080/00016340902814559 ID - Larsen2009 ER - TY - JOUR AU - Uson, P. L. J. AU - Bugano, D. D. AU - Franca, M. S. AU - Antunes, Y. P. AU - Taranto, P. AU - Kaliks, R. A. PY - 2017 DA - 2017// TI - Does time-to-chemotherapy impact the outcomes of resected ovarian Cancer? Meta-analysis of randomized and observational data JO - Int J Gynecol Cancer VL - 27 UR - https://doi.org/10.1097/IGC.0000000000000923 DO - 10.1097/IGC.0000000000000923 ID - Uson2017 ER - TY - JOUR AU - Hofstetter, G. AU - Concin, N. AU - Braicu, I. AU - Chekerov, R. AU - Sehouli, J. AU - Cadron, I. PY - 2013 DA - 2013// TI - The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study JO - Gynecol Oncol VL - 131 UR - https://doi.org/10.1016/j.ygyno.2013.07.086 DO - 10.1016/j.ygyno.2013.07.086 ID - Hofstetter2013 ER - TY - JOUR AU - Mahner, S. AU - Eulenburg, C. AU - Staehle, A. AU - Wegscheider, K. AU - Reuss, A. AU - Pujade-Lauraine, E. PY - 2013 DA - 2013// TI - Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2012.07.023 DO - 10.1016/j.ejca.2012.07.023 ID - Mahner2013 ER - TY - JOUR AU - Anuradha, S. AU - Donovan, P. J. AU - Webb, P. M. AU - Brand, A. H. AU - Goh, J. AU - Friedlander, M. PY - 2016 DA - 2016// TI - Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study JO - Acta Oncol VL - 55 UR - https://doi.org/10.3109/0284186X.2015.1054950 DO - 10.3109/0284186X.2015.1054950 ID - Anuradha2016 ER - TY - JOUR AU - Tewari, K. S. AU - Java, J. J. AU - Eskander, R. N. AU - Monk, B. J. AU - Burger, R. A. PY - 2016 DA - 2016// TI - Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG oncology/gynecologic oncology group study JO - Anna Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv500 DO - 10.1093/annonc/mdv500 ID - Tewari2016 ER - TY - JOUR AU - ElNaggar, A. C. AU - Hade, E. M. AU - O'Malley, D. M. AU - Liang, M. I. AU - Copeland, L. J. AU - Fowler, J. M. PY - 2018 DA - 2018// TI - Time to chemotherapy in ovarian cancer: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center JO - Gynecol Oncol VL - 151 UR - https://doi.org/10.1016/j.ygyno.2018.09.014 DO - 10.1016/j.ygyno.2018.09.014 ID - ElNaggar2018 ER - TY - JOUR AU - Timmermans, M. AU - Aa, M. A. AU - Lalisang, R. I. AU - Witteveen, P. O. AU - Vijver, K. K. AU - Kruitwagen, R. F. PY - 2018 DA - 2018// TI - Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer JO - Gynecol Oncol VL - 150 UR - https://doi.org/10.1016/j.ygyno.2018.07.004 DO - 10.1016/j.ygyno.2018.07.004 ID - Timmermans2018 ER - TY - JOUR AU - Lee, Y. Y. AU - Lee, J. W. AU - Lu, L. AU - Xu, W. AU - Kollara, A. AU - Brown, T. PY - 2018 DA - 2018// TI - Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer JO - Int J Gynaecol Obstet VL - 143 UR - https://doi.org/10.1002/ijgo.12653 DO - 10.1002/ijgo.12653 ID - Lee2018 ER - TY - JOUR AU - Alieva, M. AU - Rheenen, J. AU - Broekman, M. L. D. PY - 2018 DA - 2018// TI - Potential impact of invasive surgical procedures on primary tumor growth and metastasis JO - Clin Exp Metastasis VL - 35 UR - https://doi.org/10.1007/s10585-018-9896-8 DO - 10.1007/s10585-018-9896-8 ID - Alieva2018 ER - TY - JOUR AU - Lange, P. H. AU - Hekmat, K. AU - Bosl, G. AU - Kennedy, B. J. AU - Fraley, E. E. PY - 1980 DA - 1980// TI - Acclerated growth of testicular cancer after cytoreductive surgery JO - Cancer. VL - 45 UR - https://doi.org/3.0.CO;2-7 DO - 3.0.CO;2-7 ID - Lange1980 ER - TY - JOUR AU - Fisher, B. AU - Gunduz, N. AU - Coyle, J. AU - Rudock, C. AU - Saffer, E. PY - 1989 DA - 1989// TI - Presence of a growth-stimulating factor in serum following primary tumor removal in mice JO - Cancer Res VL - 49 ID - Fisher1989 ER - TY - JOUR AU - Sertoli, M. R. AU - Bruzzi, P. AU - Pronzato, P. AU - Queirolo, P. AU - Amoroso, D. AU - Mastro, L. PY - 1995 DA - 1995// TI - Randomized cooperative study of perioperative chemotherapy in breast cancer JO - J Clin Oncol VL - 13 UR - https://doi.org/10.1200/JCO.1995.13.11.2712 DO - 10.1200/JCO.1995.13.11.2712 ID - Sertoli1995 ER - TY - JOUR AU - Coffey, J. C. AU - Smith, M. J. AU - Wang, J. H. AU - Bouchier-Hayes, D. AU - Cotter, T. G. AU - Redmond, H. P. PY - 2006 DA - 2006// TI - Cancer surgery: risks and opportunities JO - Bio Essays VL - 28 ID - Coffey2006 ER - TY - JOUR AU - Yu, K. D. AU - Huang, S. AU - Zhang, J. X. AU - Liu, G. Y. AU - Shao, Z. M. PY - 2013 DA - 2013// TI - Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis JO - BMC cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-240 DO - 10.1186/1471-2407-13-240 ID - Yu2013 ER - TY - JOUR AU - Kolb, B. A. AU - Buller, R. E. AU - Connor, J. P. AU - DiSaia, P. J. AU - Berman, M. L. PY - 1992 DA - 1992// TI - Effects of early postoperative chemotherapy on wound healing JO - Obstet Gynecol VL - 79 ID - Kolb1992 ER - TY - JOUR AU - Chan, J. K. AU - Java, J. J. AU - Fuh, K. AU - Monk, B. J. AU - Kapp, D. S. AU - Herzog, T. PY - 2016 DA - 2016// TI - The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - an analysis of NRG oncology/gynecologic oncology group trials JO - Gynecol Oncol VL - 143 UR - https://doi.org/10.1016/j.ygyno.2016.09.015 DO - 10.1016/j.ygyno.2016.09.015 ID - Chan2016 ER - TY - JOUR AU - Garcia-Soto, A. E. AU - Java, J. J. AU - Nieves Neira, W. AU - Pearson, J. M. AU - Cohn, D. E. AU - Lele, S. B. PY - 2016 DA - 2016// TI - Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG oncology/gynecologic oncology group study ancillary study JO - Gynecol Oncol VL - 143 UR - https://doi.org/10.1016/j.ygyno.2016.10.003 DO - 10.1016/j.ygyno.2016.10.003 ID - Garcia-Soto2016 ER - TY - JOUR AU - Wright, J. D. AU - Herzog, T. J. AU - Neugut, A. I. AU - Burke, W. M. AU - Lu, Y. S. AU - Lewin, S. N. PY - 2012 DA - 2012// TI - Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer JO - Obstet Gynecol VL - 120 UR - https://doi.org/10.1097/AOG.0b013e31826981de DO - 10.1097/AOG.0b013e31826981de ID - Wright2012 ER - TY - JOUR AU - Wright, J. AU - Doan, T. AU - McBride, R. AU - Jacobson, J. AU - Hershman, D. PY - 2008 DA - 2008// TI - Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival JO - Br J Cancer VL - 98 UR - https://doi.org/10.1038/sj.bjc.6604298 DO - 10.1038/sj.bjc.6604298 ID - Wright2008 ER - TY - JOUR AU - Feng, Z. AU - Wen, H. AU - Bi, R. AU - Yang, W. AU - Wu, X. PY - 2016 DA - 2016// TI - Prognostic impact of the time interval from primary surgery to intravenous chemotherapy in high grade serous ovarian cancer JO - Gynecol Oncol VL - 141 UR - https://doi.org/10.1016/j.ygyno.2016.04.016 DO - 10.1016/j.ygyno.2016.04.016 ID - Feng2016 ER - TY - JOUR AU - Bommert, M. AU - Harter, P. AU - Heitz, F. AU - Bois, A. PY - 2018 DA - 2018// TI - When should Surgery be used for Recurrent Ovarian Carcinoma? JO - Clin Oncol (R Coll Radiol) VL - 30 UR - https://doi.org/10.1016/j.clon.2018.04.006 DO - 10.1016/j.clon.2018.04.006 ID - Bommert2018 ER - TY - JOUR AU - Harter, P. AU - Sehouli, J. AU - Reuss, A. AU - Hasenburg, A. AU - Scambia, G. AU - Cibula, D. PY - 2011 DA - 2011// TI - Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the multicenter intergroup study DESKTOP II. A project of the AGO Kommission OVAR, AGO study group, NOGGO, AGO-Austria, and MITO JO - Int J Gynecol Cancer VL - 21 UR - https://doi.org/10.1097/IGC.0b013e31820aaafd DO - 10.1097/IGC.0b013e31820aaafd ID - Harter2011 ER - TY - JOUR AU - Bois, A. AU - Vergote, I. AU - Ferron, G. AU - Reuss, A. AU - Meier, W. AU - Greggi, S. PY - 2017 DA - 2017// TI - Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20 JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.15_suppl.5501 DO - 10.1200/JCO.2017.35.15_suppl.5501 ID - Bois2017 ER -